James Craig Hartman
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$3.6MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $3.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 6, 2023 | NIH | SBIR Phase II Completion of IND-enabling studies required for first-in-human studies of a novel oral therapeutic agent for treating pulmonary fibrosis | $709K | MDI THERAPEUTICS INC |
| Mar 4, 2022 | NIH | SBIR Phase II Completion of IND-enabling studies required for first-in-human studies of a novel oral therapeutic agent for treating pulmonary fibrosis | $1.0M | MDI THERAPEUTICS INC |
| Aug 12, 2020 | NIH | SBIR Phase II Development of a small molecule inhibitor of PAI-1 for the treatment of diffuse cutaneous systemic sclerosis | $747K | MDI THERAPEUTICS INC |
| Aug 29, 2019 | NIH | SBIR Phase II Development of a small molecule inhibitor of PAI-1 for the treatment of diffuse cutaneous systemic sclerosis | $747K | MDI THERAPEUTICS INC |
| Dec 21, 2018 | NIH | SBIR Phase I Preclinical development of a first in class therapeutic for treating idiopathic pulmonary fibrosis | $225K | MDI THERAPEUTICS INC |
| Jul 31, 2018 | NIH | SBIR Phase I Development of a small molecule inhibitor of PAI-1 for the treatment of diffuse cutaneous systemic sclerosis | $217K | MDI THERAPEUTICS INC |
Peer ranks
Federal funding#460
Awards as PI#315
Patents#273
Companies
- MDI THERAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.